Recombinant activated factor VII for non-hemophiliac bleeding patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hematology
Reference55 articles.
1. A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors
2. Prospective, Randomised Trial of Two Doses of rFVIIa (NovoSeven) in Haemophilia Patients with Inhibitors Undergoing Surgery
3. Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor
4. Platelet activity of high-dose factor VIIa is independent of tissue factor
5. How factor VIIa works in hemophilia
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency;Blood Coagulation & Fibrinolysis;2015-04
2. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann’s thrombasthenia;Expert Review of Hematology;2014-11-11
3. Recombinant factor Vila as haemostatic therapy in advanced liver disease;BLOOD TRANSFUS-ITALY;2013
4. Five Days of No Anticoagulation or Antiplatelet Therapy and NovoSeven Administration in a HeartWare HVAD Patient;Artificial Organs;2012-05-20
5. Recombinant Activated Factor VII Usage in Life Threatening Hemorrhage: A Pediatric Experience;The Indian Journal of Pediatrics;2011-02-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3